Key result
Treatment with only low molecular weight heparin successfully managed a case of upper limb deep vein thrombosis.
Why the study?
Does low molecular weight heparin monotherapy successfully treat upper limb deep vein thrombosis?
Case Report (n=1)
Does low molecular weight heparin monotherapy successfully treat upper limb deep vein thrombosis?
This case report suggests that low molecular weight heparin alone may be an effective treatment for upper limb deep vein thrombosis.
Answers are grounded in this paper and cite their sources.
LMWH monotherapy may treat upper limb DVT; hypothesis-generating and should not change practice without controlled trials.
Shah MK, Black-Schaffer RM: Treatment of upper limb deep vein thrombosis with low molecular weight heparin. Am J Phys Med Rehabil 2003;82:415–417. Upper limb deep vein thrombosis has been an under-recognized disease; however, physicians’ awareness of it as a cause of arm pain and edema is increasing. Previously thought of as benign, upper limb deep vein thrombosis has been shown in recent studies to pose a significant risk for pulmonary embolus and death. The need for treatment is now recognized; however, effective treatments for upper limb deep vein thrombosis have not been fully defined. Anticoagulation with oral agents is known to be successful in preventing complications and recurrence. This report presents the first case of upper limb deep vein thrombosis successfully treated with only low molecular weight heparin.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2003) conducted a case report in Upper limb deep vein thrombosis (n=1). Low molecular weight heparin was evaluated on Successful treatment of upper limb deep vein thrombosis. Treatment with only low molecular weight heparin successfully managed a case of upper limb deep vein thrombosis.
Synapse has enriched 10 related papers. Consider them for comparative context: